Abstract A 13 year old Asian girl presenting with apparent hysterical paralysis and subsequent rapid cycling bipolar mood disorder was found to have biochemical evidence of pseudohypoparathyroidism type II. The mood disorder responded to treatment
Pseudohypoparathyroidism comprises a heterogeneous group of genetically determined disorders which are still to be fully characterised in molecular and genetic terms. Pseudohypoparathyroidism presents with biochemical evidence of parathyroid hormone resistance, which is shown clinically by deficient phosphaturic and calcaemic responses to exogenous parathyroid hormone.
We report an unusual psychiatric presentation of a child with pseudohypoparathyroidism and describe the clinical and biochemical features of other members of the child's family.
guineous. The child was engaged to a man in Pakistan.
The child was the fourth of eight children aged 3-21 years. The three youngest and the eldest had all had recurrent (probably febrile) convulsions, the eldest having had more than 10 fits as a child. The third youngest, E, a boy aged 10, had testicular feminisation syndrome and was initially raised as a girl (to the age of 5 years). He is thought by the family to have magical powers.
The child's headteacher telephoned personally with a school report. He said that, until a month before admission, G had been a model pupil but recently she had become unpopular and had started to tell bizarre stories of her home life.
Later during her admission, prominent mood swings from hour to hour and day to day were noted. At times she dressed in Western clothes and was found dancing alone enthusiastically; later the same day she changed into dull cultural clothes and wandered with her head bowed and covered looking miserable. Manchester depression and mania nurse rating scales' were performed, which supported the clinical impression of significant mood swings even within the same day, and a diagnosis of rapid cycling bipolar (manic-depressive) mood disorder was made.
An Asian girl aged Time after PTH infusion (hours) Figure 1 Renal cAMPuric response to intravenous infusion ofparathyroid hormone (PTH) in eight members of the same family. One subject (B) shows no cAMPunic response and has type Ib pseudohypoparathyroidism.
These findings prompted investigation of the other immediate family members with calcium, parathyroid hormone, and parathyroid hormone infusion tests (see figs 1 and 2). G's father (B) had normal calcium metabolism but showed no increase in cAMPuria or phosphaturia with parathyroid hormone infusion, suggesting type I pseudohypoparathyroidism. G's sisters F (12 years) and H (14 years) had the same blunting of phosphate excretion but a normal increase in cAMP with parathyroid hormone infusion, consistent with a diagnosis of type II pseudohypoparathyroidism. H was normocalcaemic; F was hypocalcaemic (1 8 mmol/l) initially, but her serum calcium later returned to normal without treatment. These girls were also above the 97th centile for weight, had greatly increased parathyroid hormone concentrations, and were not deficient in vitamin D.
There were good biochemical and clinical responses to treatment with a vitamin D analogue. The mood swings disappeared almost at once and G returned to school and was re-elected form captain by her peers.
Discussion
In the original description, Albright et al described three patients with hypocalcaemia, Time after PTH infusion (hours) Our index case presented with overt clinical and biochemical evidence of disease but had previously been well. In addition, other members of the family with biochemical evidence of pseudohypoparathyroidism had no clinical signs nor symptoms. Factors precipitating overt symptoms in subjects with subclinical pseudohypoparathyroidism are unknown, but vitamin D deficiency might be a candidate in our family. It is unclear, though possible, that the father's psychiatric history was related to his abnormal calcium metabolism (type Ib pseudohypoparathyroidism). Overt pseudohypoparathyroidism has been described in a 34 year old woman with previous subclinical type II pseudohypoparathyroidism, presenting during the second half of pregnancy.9
Resistance to hormones other than parathyroid hormone, including thyroid, gonadotrophins, prolactin, and glucagon is well described in type Ia (Albright's hereditary osteodystrophy phenotype) pseudohypoparathyroidism and screening for hypothyroidism is mandatory in these children, but it is not classically described in type Ib or type II pseudohypoparathyroidism as seen here.
It is interesting to note that the father and four of the siblings had recurrent convulsions in early childhood. Pseudohypoparathyroidism presenting with convulsions has been described'0 and neuromuscular symptoms secondary to hypocalcaemia such as paresthesias, tetany, and seizures (and prolonged QT interval on electrocardiogram) are well described in pseudohypoparathyroidism. 5 16 It has also been suggested that the action of lithium in the treatment of mood disorders may be mediated by its blocking of inositol-1,4,5-triphosphate, an intracellular second messenger, which affects the increase in ionic intracellular calcium in secretory cells triggering neurotransmitter release. 17 Although the intracellular calcium concentration in pseudohypoparathyroidism is low, '8 clouding the relation between the findings in other studies of bipolar mood disorder and our patient, it nevertheless seems likely that the psychiatric symptoms and their rapid resolution in our patient may be attributable to the disorder in calcium metabolism and its subsequent treatment. Although mental retardation is common in type Ia (Albright' 
